Cocrystal Pharma (COCP) Convertible Debt (2017 - 2018)
Cocrystal Pharma (COCP) reported Convertible Debt of $2.0 million for Q1 2018, up 102.48% sequentially from $1.0 million in Q4 2017.
Cocrystal Pharma (COCP) Convertible Debt (2017 - 2018) Analysis & Trends
Cocrystal Pharma (COCP) has 2 years of Convertible Debt data on file, last reported at $2.0 million in Q1 2018.
- For the quarter ending Q1 2018, Convertible Debt changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2018 stood at $2.0 million (changed N/A YoY), and the FY2017 full-year result was $1.0 million, changed N/A from the prior year.
- Convertible Debt improved to $2.0 million in Q1 2018, from $1.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $2.0 million in Q1 2018 to a low of $1.0 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 2.04 Mn |
| Dec 31, 2017 | 1.01 Mn |